Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1993 Nov 6;307(6913):1195–1199. doi: 10.1136/bmj.307.6913.1195

Diabetic retinopathy.

E M Kohner 1
PMCID: PMC1679290  PMID: 8251848

Full text

PDF
1199

Images in this article

1195FIG 2
on p.1195
1196FIG 3
on p.1196
1197FIG 5
on p.1197
1198FIG 6
on p.1198

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brinchmann-Hansen O., Dahl-Jørgensen K., Hanssen K. F., Sandvik L. The response of diabetic retinopathy to 41 months of multiple insulin injections, insulin pumps, and conventional insulin therapy. Arch Ophthalmol. 1988 Sep;106(9):1242–1246. doi: 10.1001/archopht.1988.01060140402041. [DOI] [PubMed] [Google Scholar]
  2. Cagliero E., Maiello M., Boeri D., Roy S., Lorenzi M. Increased expression of basement membrane components in human endothelial cells cultured in high glucose. J Clin Invest. 1988 Aug;82(2):735–738. doi: 10.1172/JCI113655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Davies E. G., Petty R. G., Kohner E. M. Long term effectiveness of photocoagulation for diabetic maculopathy. Eye (Lond) 1989;3(Pt 6):764–767. doi: 10.1038/eye.1989.119. [DOI] [PubMed] [Google Scholar]
  4. Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy. A multicenter randomized controlled clinical trial. The DAMAD Study Group. Diabetes. 1989 Apr;38(4):491–498. [PubMed] [Google Scholar]
  5. Engerman R. L., Kern T. S. Experimental galactosemia produces diabetic-like retinopathy. Diabetes. 1984 Jan;33(1):97–100. doi: 10.2337/diab.33.1.97. [DOI] [PubMed] [Google Scholar]
  6. Eschwege E., Guyot-Argenton C., Aubry J. P., Tchobroutsky G. Effect of multiple daily insulin injections on the course of diabetic retinopathy. Diabetes. 1976 May;25(5):463–469. [PubMed] [Google Scholar]
  7. Grunwald J. E., Brucker A. J., Schwartz S. S., Braunstein S. N., Baker L., Petrig B. L., Riva C. E. Diabetic glycemic control and retinal blood flow. Diabetes. 1990 May;39(5):602–607. doi: 10.2337/diab.39.5.602. [DOI] [PubMed] [Google Scholar]
  8. Hansen A. P. Abnormal serum growth hormone response to exercise in juvenile diabetics. J Clin Invest. 1970 Aug;49(8):1467–1478. doi: 10.1172/JCI106364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Herman I. M., D'Amore P. A. Microvascular pericytes contain muscle and nonmuscle actins. J Cell Biol. 1985 Jul;101(1):43–52. doi: 10.1083/jcb.101.1.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hyer S. L., Sharp P. S., Brooks R. A., Burrin J. M., Kohner E. M. Serum IGF-1 concentration in diabetic retinopathy. Diabet Med. 1988 May-Jun;5(4):356–360. doi: 10.1111/j.1464-5491.1988.tb01005.x. [DOI] [PubMed] [Google Scholar]
  11. Kador P. F., Akagi Y., Takahashi Y., Ikebe H., Wyman M., Kinoshita J. H. Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors. Arch Ophthalmol. 1990 Sep;108(9):1301–1309. doi: 10.1001/archopht.1990.01070110117035. [DOI] [PubMed] [Google Scholar]
  12. Klein B. E., Moss S. E., Klein R. Longitudinal measure of glycemic control and diabetic retinopathy. Diabetes Care. 1987 May-Jun;10(3):273–277. doi: 10.2337/diacare.10.3.273. [DOI] [PubMed] [Google Scholar]
  13. Lorenzi M. Glucose toxicity in the vascular complications of diabetes: the cellular perspective. Diabetes Metab Rev. 1992 Jul;8(2):85–103. doi: 10.1002/dmr.5610080202. [DOI] [PubMed] [Google Scholar]
  14. Orlidge A., D'Amore P. A. Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J Cell Biol. 1987 Sep;105(3):1455–1462. doi: 10.1083/jcb.105.3.1455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Patel V., Rassam S., Newsom R., Wiek J., Kohner E. Retinal blood flow in diabetic retinopathy. BMJ. 1992 Sep 19;305(6855):678–683. doi: 10.1136/bmj.305.6855.678. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Press M., Tamborlane W. V., Sherwin R. S. Importance of raised growth hormone levels in mediating the metabolic derangements of diabetes. N Engl J Med. 1984 Mar 29;310(13):810–815. doi: 10.1056/NEJM198403293101302. [DOI] [PubMed] [Google Scholar]
  17. Sharp P. S., Fallon T. J., Brazier O. J., Sandler L., Joplin G. F., Kohner E. M. Long-term follow-up of patients who underwent yttrium-90 pituitary implantation for treatment of proliferative diabetic retinopathy. Diabetologia. 1987 Apr;30(4):199–207. doi: 10.1007/BF00270416. [DOI] [PubMed] [Google Scholar]
  18. Shepherd J., Packard C. J. Lipoprotein receptors and atherosclerosis. Clin Sci (Lond) 1986 Jan;70(1):1–6. doi: 10.1042/cs0700001. [DOI] [PubMed] [Google Scholar]
  19. Sullivan P. M., Davies G. E., Caldwell G., Morris A. C., Kohner E. M. Retinal blood flow during hyperglycemia. A laser Doppler velocimetry study. Invest Ophthalmol Vis Sci. 1990 Oct;31(10):2041–2045. [PubMed] [Google Scholar]
  20. Sullivan P., Caldwell G., Alexander N., Kohner E. Long-term outcome after photocoagulation for proliferative diabetic retinopathy. Diabet Med. 1990 Nov;7(9):788–794. doi: 10.1111/j.1464-5491.1990.tb01493.x. [DOI] [PubMed] [Google Scholar]
  21. de la Rubia G., Oliver F. J., Inoguchi T., King G. L. Induction of resistance to endothelin-1's biochemical actions by elevated glucose levels in retinal pericytes. Diabetes. 1992 Dec;41(12):1533–1539. doi: 10.2337/diabetes.41.12.1533. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES